← All organizations
Highest phase reached
Phase 3
Acquired by Assertio on May 15, 2020
Timeline
Drugs by trial phase (9 distinct, 18 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Marketed drugs (6)
Recent trials (23)
- NCT02716857Lead sponsorPhase 3Mar 1, 2016
- NCT02603705Lead sponsorPhase 3Jan 1, 2016
- NCT02102516Lead sponsorPhase 3Mar 1, 2014
- NCT00802308Lead sponsorPhase 1Dec 1, 2008
- NCT00802308Study directorPhase 1Dec 1, 2008
- NCT00802087Lead sponsorPhase 1Nov 1, 2008
- NCT00802087Study directorPhase 1Nov 1, 2008
- NCT00801788Lead sponsorPhase 1Sep 1, 2008
- NCT00801788Study directorPhase 1Sep 1, 2008
- NCT00446069Study directorPhase 2Aug 1, 2007
- NCT00446069Lead sponsorPhase 2Aug 1, 2007
- NCT00483717Lead sponsorPhase 2Jul 1, 2007
- NCT01363076Lead sponsorPhase 1Jun 1, 2007
- NCT00444834Study directorPhase 2Apr 1, 2007
- NCT00444834Lead sponsorPhase 2Apr 1, 2007
Details
- Founded
- Vaerlose, DK Jun 1, 1995
- Last known activity
- Jan 9, 2017
Notes
formerly Egalet A/S